Results

Total Results: 1,636 records

Showing results for "treated".

201. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - In September 2014, FDA approved Iluvien for treating DME in patients “who have been previously treated … However, experts also cautioned that cost savings could be nullified if patients need to be treated … The preliminary data indicate a dose-dependent improvement in glycemic control in patients treated … Patients treated with Afrezza had a 40 mL (95% CI, -80 to -1) greater decline from baseline in forced … Alimera Sciences announces first patient treated with commercially available Iluvien.

202. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Patients treated with the drug were reported to have a longer median time to the first exacerbation … (266 days vs. 174 days) and less-frequent exacerbations than patients treated with placebo. … time to first exacerbation was 266 days (95% confidence interval [CI], 227 to 313) among patients treated … Patients treated with azithromycin experienced 156 respiratory-related hospitalizations compared with … Patients treated with azithromycin three times weekly showed clinically significant improvement in

203. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
     August 10, 2010 - the time of the study or of the publication • No age limit for population • Diagnosed with or treated … For key question two, the population will include subjects of any age who have been treated for ADHD … question three, the population will include subjects of any age who have been diagnosed with ADHD or treated

204. Introduction (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
     February 01, 2009 - Records from 23342 patients with treated RA were analyzed. … However, information on RA treated in the community is limited.2-4 Moreover, pain control is an important … biologics (alone or in combination with other DMARDs) started in 1998 and by the end of 2004, 22% of treated

205. Gout-managment-protocol-141103 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
     November 03, 2014 - Although initial episodes may be brief and rare, acute episodes if untreated, under-treated or improperly … treated, may increase in frequency and duration and lead to the development of chronic gout. … fenofibrate; the angiotensin 2 receptor blocker, losartan; and calcium channel blockers (in patients being treated … chronic gout.13, 14 However, the majority of individuals with gout are initially seen, diagnosed, and treated

206. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - Denosumab 2° Outcome: Adverse events of treatement Factors affecting outcomes Postmenopausal women Men treated … Moderate-High Among subjects treated with glucocorticoids, fracture risk reduction was demonstrated for … evidence (continued) Strength of Evidence Conclusion Moderate Reduction in fracture risk for subjects treated … Moderate Teriparatide-treated participants showed a significant increase in hypercalcemia. … Moderate A small number of clinical trials have reported an increased risk of hypocalcemia in patients treated

207. Disparities-Quality-Improvement Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
     August 01, 2012 - health outcomes such as blood pressure and HbA1c); process measures (e.g., proportion of patients treated … at the VA clinic implementing the QI strategy compared with patients treated at the usual-care clinic … • Patients with adequate health literacy were equally likely to pursue CRC screening when treated … at the VA clinic implementing the QI strategy compared with patients treated at the usual-care clinic … Service use and outcomes among elderly persons with low incomes being treated for depression.

208. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
     November 22, 2011 - both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated … Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function … Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with … P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated

209. Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
     April 01, 2012 - prevents patients from reaching the point of disability at a lower rate than if they had not been treated … The fact that these two populations were retrospectively identified from subjects being treated at … The ideal study would include treated and untreated arms, similar to the EMGT, but with longer follow-up … and those in the untreated group, the mean difference seen between the treated and untreated group … For example, individual treated with numerous medications for a 10 year period of time, followed by

210. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
     October 26, 2012 - A sampling of patients who have been treated for CDI and developed recurrence (cases) or did not develop … Patients who have been treated for CDI and developed recurrence (cases) or did not develop recurrence … Patients who were treated for CDI are classified according to concomitant antibiotic status and followed … Individuals with CDI who were treated with novel therapy or standard care are included and followed … Individuals with CDI recurrence who were treated with novel therapy or standard care are included and

211. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
     March 11, 2010 - Myxedema coma is a life-threatening complication of untreated or under-treated hypothyroidism, usually … life-threatening condition that results from an acute illness superimposed on undiagnosed or under-treated … adherence or under-treatment with levothyroxine, recent hospitalization for severe illness, previously treated … hypothyroidism, but it may prevent symptoms of overt disease in those who do progress.2 Hyperthyroidism is treated

212. Comparative Effectiveness and Safety of New Therapies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
     July 01, 2010 - effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated … Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients … Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated … Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated

213. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diabetic-neuropathy/research-2017

214. Liver-Cancer-Therapy Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
     November 28, 2012 - the TEP was that due to changes in clinical practice and treatment regimens, outcomes for patients treated … Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective … Patients treated with ablative and transarterial or radiation therapy strategies represent two distinct

215. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - “Overproducers” were treated preferentially with allopurinol, whereas “underexcretors” were treated … angiotensin 2 receptor blocker, losartan; estrogen; and calcium channel blockers (in patients being treated … Comprehensive dietary education in treated gout patients does not further improve serum urate. … A retrospective, hospital-based study involving 101 patients consecutively treated with allopurinol … Assessing SUA, flare rates, and Tophi in patients with gout treated xanthine oxidase inhibitors in

216. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
     February 01, 2015 - DEMENTIA INCLUDING ALZHEIMER'S #04 AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 04: Dementia (Including Alzheimer’s Disease) Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road …

217. Alcohol-Misuse-Drug-Therapy Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
     January 27, 2012 - Two studies found no significant difference between naltrexone- and placebo-treated subjects.45,46 One … Compared with placebo, patients treated with acamprosate had a higher risk of anxiety, diarrhea, and … vomiting; those treated with naltrexone had a higher 12 risk of dizziness, nausea, and vomiting … ; and those treated with nalmefene had a higher risk of dizziness, headache, insomnia, nausea, and … included studies were either subgroup analyses of trials or prospective cohort studies of people treated

218. Executive Summary_Comparative Effectiveness Review No. 254: Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-254-rural-telehealth-executive-summary.pdf
     December 01, 2022 - attack. or chest pain at rural hospitals: o May result in similar rates of mortality when patients are treated … o May result in similar time to treatment when patients are treated locally as opposed to transferred

219. Rapid Response_Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
     November 01, 2024 - disease (ESRD), is defined by eGFR below 15 mL/min/1.73m2 and includes individuals with kidney failure treated … 25.1** 14.3 • UACR decreased (p < 0.001) Maheshwari 202328; India; Federal; 3-4; High; CRP: Treated … group (p < 0.001) • IL-1β lower in treated group (p = 0.03) • No significant changes in creatinine … • Longer survival in treated patients on HD. … group (p < 0.001) • IL-1b lower in treated group (p = 0.03) • No significant changes in creatinine

220. Radiotherapy Treatments for Head and Neck Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_clinician.pdf
     August 01, 2015 - Radiotherapy Treatments for Head and Neck Cancer Radiotherapy Treatments for Head and Neck Cancer Background Clinical Bottom Line and stereotactic body RT (SBRT). Charged particle-based conformal external-beam RT modalities, such as proton-beam RT (PBT), are also available to treat head and neck cancer, althou…